TY - JOUR
T1 - Burden of delirium on mortality and healthcare resource utilization in geriatric patients hospitalized for inflammatory bowel disease
AU - Aldiabat, Mohammad
AU - Aleyadeh, Wesam
AU - Rana, Tabeer
AU - Ta’ani, Omar Al
AU - Alahmad, Majd
AU - Ayoub, Malek
AU - Jaber, Fouad
AU - Obeidat, Adham
AU - Numan, Laith
AU - Manvar, Amar
AU - Alhuneafat, Laith
N1 - Publisher Copyright:
© Copyright © 2024 Baylor University Medical Center.
PY - 2024
Y1 - 2024
N2 - Background: Delirium is prevalent in elderly patients, linked to elevated mortality rates, heightened healthcare resource use, and caregiver burden. Inflammatory bowel disease (IBD) poses various delirium risk factors, yet the impact on geriatric IBD patient outcomes remains unexplored. Methods: Using 2016–2019 National Inpatient Sample data, we identified ≥65-year-old patients admitted for IBD (Crohn’s, ulcerative colitis) management stratified by delirium presence as a secondary diagnosis. The study aimed to assess delirium’s impact on geriatric IBD patient outcomes. Results: Among 67,534 elderly IBD admissions, 0.7% (470) developed delirium. The delirium group had a 4.8-fold increase in in-hospital mortality risk (odds ratio 4.80, P < 0.001, 95% confidence interval [CI] 1.94–11.8). IBD patients with delirium experienced prolonged length of stay (adjusted mean difference 5.15 days, 95% CI 3.24–7.06, P < 0.001) and increased care costs (adjusted mean difference $48,328, 95% CI $26,485–$70,171, P < 0.001) compared to those without delirium. Conclusion: Elderly IBD patients with delirium face higher mortality risk, prolonged hospitalization, and increased healthcare costs. Clinicians should recognize delirium’s detrimental effects in this vulnerable group and adhere to preventive protocols for improved care.
AB - Background: Delirium is prevalent in elderly patients, linked to elevated mortality rates, heightened healthcare resource use, and caregiver burden. Inflammatory bowel disease (IBD) poses various delirium risk factors, yet the impact on geriatric IBD patient outcomes remains unexplored. Methods: Using 2016–2019 National Inpatient Sample data, we identified ≥65-year-old patients admitted for IBD (Crohn’s, ulcerative colitis) management stratified by delirium presence as a secondary diagnosis. The study aimed to assess delirium’s impact on geriatric IBD patient outcomes. Results: Among 67,534 elderly IBD admissions, 0.7% (470) developed delirium. The delirium group had a 4.8-fold increase in in-hospital mortality risk (odds ratio 4.80, P < 0.001, 95% confidence interval [CI] 1.94–11.8). IBD patients with delirium experienced prolonged length of stay (adjusted mean difference 5.15 days, 95% CI 3.24–7.06, P < 0.001) and increased care costs (adjusted mean difference $48,328, 95% CI $26,485–$70,171, P < 0.001) compared to those without delirium. Conclusion: Elderly IBD patients with delirium face higher mortality risk, prolonged hospitalization, and increased healthcare costs. Clinicians should recognize delirium’s detrimental effects in this vulnerable group and adhere to preventive protocols for improved care.
KW - Geriatrics
KW - inflammatory bowel disease
KW - outcomes research
UR - http://www.scopus.com/inward/record.url?scp=85191151228&partnerID=8YFLogxK
U2 - 10.1080/08998280.2024.2342106
DO - 10.1080/08998280.2024.2342106
M3 - Article
C2 - 38910812
AN - SCOPUS:85191151228
SN - 0899-8280
VL - 37
SP - 509
EP - 515
JO - Baylor University Medical Center Proceedings
JF - Baylor University Medical Center Proceedings
IS - 4
ER -